Johnson & Johnson’s “Bold” Stelara campaign found a new audience during the televised Olympics. Its strategy? Match athletic perseverance with its message of strength for people living with Crohn’s ...
Johnson & Johnson’s subsidiary Janssen has launched the latest iteration of its “UnstoppaBOLD” campaign for Stelara, an immunosuppressive drug used to treat Crohn’s disease and psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results